Found: 5
Select item for more details and to access through your institution.
Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19.
- Published in:
- Vaccines, 2022, v. 10, n. 11, p. 1864, doi. 10.3390/vaccines10111864
- By:
- Publication type:
- Article
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
- Published in:
- Microorganisms, 2022, v. 10, n. 8, p. 1639, doi. 10.3390/microorganisms10081639
- By:
- Publication type:
- Article
Breakthrough infections and waning immune responses with ChAdOx1 nCoV‐19 or mRNA vaccine in healthcare workers.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 4, p. 1, doi. 10.1002/ctm2.804
- By:
- Publication type:
- Article
Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural Severe Acute Respiratory Syndrome Coronavirus 2 Infection (With or Without Subsequent Coronavirus Disease 2019 [COVID-19] Vaccination) Versus 2-Dose COVID-19 Vaccination
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 12, p. 2243, doi. 10.1093/cid/ciac435
- By:
- Publication type:
- Article
Immune Responses to the ChAdOx1 nCoV-19 and BNT162b2 Vaccines and to Natural Coronavirus Disease 2019 Infections Over a 3-Month Period.
- Published in:
- 2022
- By:
- Publication type:
- journal article